Novoray(SH:688300)2025-04-28 08:50Financial Performance - The company's operating revenue for Q1 2025 was CNY 238,689,614.37, representing an 18.00% increase compared to CNY 202,281,462.28 in the same period last year[4]. - Net profit attributable to shareholders was CNY 63,037,699.67, up 21.99% from CNY 51,675,319.33 year-on-year[4]. - The net profit after deducting non-recurring gains and losses was CNY 58,612,076.79, reflecting a 28.66% increase from CNY 45,554,579.27 in the previous year[4]. - Operating profit for the first quarter of 2025 reached CNY 73,435,039.56, compared to CNY 58,689,895.93 in the previous year, indicating a year-over-year increase of about 25.1%[18]. - The company reported a total comprehensive income of CNY 62,993,491.33 for Q1 2025, compared to CNY 51,282,778.27 in Q1 2024, marking an increase of about 22.7%[18]. - The basic and diluted earnings per share for Q1 2025 were both CNY 0.34, an increase from CNY 0.28 in Q1 2024[18]. Cash Flow and Liquidity - The net cash flow from operating activities was CNY 18,983,528.40, a significant recovery from a negative cash flow of CNY -15,022,428.62 in the same period last year[4]. - Cash flow from operating activities generated a net amount of CNY 18,983,528.40 in Q1 2025, a significant improvement from a net outflow of CNY 15,022,428.62 in Q1 2024[19]. - Cash and cash equivalents decreased to ¥210,750,385.23 as of March 31, 2025, down from ¥319,538,268.75 at the end of 2024, indicating liquidity challenges[12]. - The cash and cash equivalents at the end of Q1 2025 totaled CNY 195,170,866.45, down from CNY 221,708,087.26 at the end of Q1 2024[20]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,966,443,075.07, a slight decrease of 0.28% from CNY 1,971,962,660.24 at the end of the previous year[5]. - Total liabilities decreased to ¥395,773,745.86 from ¥464,286,822.36, reflecting a reduction in financial obligations[14]. - Accounts receivable decreased slightly to ¥228,957,134.34 from ¥240,611,863.34, suggesting improved collection efforts[12]. - Inventory increased to ¥118,995,210.45 from ¥105,670,286.75, indicating potential stockpiling or increased production[13]. Research and Development - Research and development expenses totaled CNY 13,430,302.98, accounting for 5.63% of operating revenue, down from 6.42%[5]. - The company reported a significant increase in research and development expenses to ¥13,430,302.98 in Q1 2025, compared to ¥12,976,858.77 in Q1 2024, highlighting a commitment to innovation[17]. Shareholder Information - Shareholders' equity attributable to shareholders increased by 4.18% to CNY 1,570,669,329.21 from CNY 1,507,675,837.88[5]. - The total number of common shareholders at the end of the reporting period was 7,952[9]. Tax and Other Comprehensive Income - The company incurred a tax expense of CNY 9,562,129.93 in Q1 2025, compared to CNY 7,016,886.50 in Q1 2024, reflecting an increase of approximately 36.1%[18]. - The company reported a decrease in other comprehensive income, with a net amount of CNY -44,208.34 in Q1 2025, compared to CNY -392,541.06 in Q1 2024[18].